The below conversation between Managed Healthcare Executive and Kristin Begley, Pharm.D., chief commercial officer of Judi Health/Capital Rx, has been edited for length and clarity.

MHE: Judi Health is now valued at $3.25 billion—more than double what it was last year. What does this say about how investors view the future of PBMs and health benefits overall?

Kristin: I think it’s a very exciting time, not only for us, but for advancing healthcare in America. This valuation of Judi Health really reflects a broader investment belief that the future of healthcare benefits lies in transparency, integration and technology-driven efficiency—areas where healthcare has historically lagged.

We’re witnessing the end of the dinosaurs in healthcare. It’s been far too long since infrastructure

See Full Page